Literature DB >> 8394360

Purification of multiple forms of glial growth factor.

A D Goodearl1, J B Davis, K Mistry, L Minghetti, M Otsu, M D Waterfield, P Stroobant.   

Abstract

Glial growth factors (GGFs) were purified from bovine pituitaries using an in vitro rat Schwann cell mitogenesis assay. In addition to an approximately 34-kDa species termed GGF-I, similar in molecular mass to a previously identified molecule (Lemke, G. E., and Brockes, J. P. (1984) J. Neuroscience 4, 75-83), two species named GGF-II and GGF-III were characterized with apparent molecular masses of approximately 59 and approximately 45 kDa, respectively. Highly purified preparations of all species share a similar dose-dependent stimulation of Schwann cell DNA synthesis at nanomolar concentrations. Forskolin synergizes with all three GGFs, shifting their dose dependence 3-8-fold into the sub-nanomolar range. The GGFs, which contain N-linked carbohydrate groups not essential for their in vitro mitogenic effects, are three distinct members of a novel family of glial cell mitogens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394360

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development.

Authors:  T Vartanian; G Corfas; Y Li; G D Fischbach; K Stefansson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

2.  Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration.

Authors:  S L Carroll; M L Miller; P W Frohnert; S S Kim; J A Corbett
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

Review 3.  Neuregulins in glial cells.

Authors:  T D Raabe; A Francis; G H DeVries
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus.

Authors:  Y Liu; B Ford; M A Mann; G D Fischbach
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 5.  Growth factors: potential therapeutic applications in neurology.

Authors:  J Drago; T J Kilpatrick; S A Koblar; P S Talman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

6.  Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth.

Authors:  N K Mahanthappa; E S Anton; W D Matthew
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

7.  The role of neuregulin-1 in the response to nerve injury.

Authors:  Florence R Fricker; David Lh Bennett
Journal:  Future Neurol       Date:  2011-11

8.  Heregulins and the ErbB-2/3/4 receptors in gliomas.

Authors:  M Westphal; L Meima; E Szonyi; J Lofgren; H Meissner; W Hamel; K Nikolics; M X Sliwkowski
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 9.  Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage.

Authors:  Olaf Dammann; Wolfgang Bueter; Alan Leviton; Pierre Gressens; Christiane E L Dammann
Journal:  Neonatology       Date:  2007-11-09       Impact factor: 4.035

10.  Generation and characterization of neuregulin-2-deficient mice.

Authors:  Joanne M Britto; Sherralee Lukehurst; Renae Weller; Chris Fraser; Yubin Qiu; Paul Hertzog; Samantha J Busfield
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.